S. 5571

Biosimilars Access and Affordability Act

3 cosponsors

Where it stands

Read twice and referred to the Committee on Finance. (Sep 28)

No roll-call votes yet.

No official summary yet.

Sec. 1. Short title

Sec. 2. Change of when biosimilars are eligible for price negotiations